Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Nature Communications
|
May 1, 2019
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β
Martina Rossi, Gabriele Bucci, Dario Rizzotto, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 15, 2014
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction
Joana Soares, Nuno A L Pereira, Ângelo Monteiro, et al.
Nucleic Acids Research
|
April 18, 2023
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis
Paola Briata, Luca Mastracci, Ettore Zapparoli, et al.
Oncotarget
|
January 7, 2016
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule
Joana Soares, Liliana Raimundo, Nuno A L Pereira, et al.
Nature Communications
|
July 1, 2017
Inherited determinants of early recurrent somatic mutations in prostate cancer
Alessandro Romanel, Sonia Garritano, Blerta Stringa, et al.
Frontiers in Molecular Biosciences
|
June 20, 2022
Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
Vera V Grinkevich, Aparna Vema, Karin Fawkner, et al.
Nature Cell Biology
|
September 22, 2020
SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy
Fabio Lauria, Paola Bernabò, Toma Tebaldi, et al.
Pigment Cell & Melanoma Research
|
November 20, 2015
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma
Virginia Andreotti, Alessandra Bisio, Brigitte Bressac-de Paillerets, et al.
Cancers
|
August 14, 2019
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
Sara Gomes, Bartolomeo Bosco, Joana B Loureiro, et al.
Cell Reports
|
April 14, 2021
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Helena Ramos, Maria I L Soares, Joana Silva, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Nature Communications
|
May 1, 2019
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β
Martina Rossi, Gabriele Bucci, Dario Rizzotto, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 15, 2014
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction
Joana Soares, Nuno A L Pereira, Ângelo Monteiro, et al.
Nucleic Acids Research
|
April 18, 2023
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis
Paola Briata, Luca Mastracci, Ettore Zapparoli, et al.
Oncotarget
|
January 7, 2016
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule
Joana Soares, Liliana Raimundo, Nuno A L Pereira, et al.
Nature Communications
|
July 1, 2017
Inherited determinants of early recurrent somatic mutations in prostate cancer
Alessandro Romanel, Sonia Garritano, Blerta Stringa, et al.
Frontiers in Molecular Biosciences
|
June 20, 2022
Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
Vera V Grinkevich, Aparna Vema, Karin Fawkner, et al.
Nature Cell Biology
|
September 22, 2020
SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy
Fabio Lauria, Paola Bernabò, Toma Tebaldi, et al.
Pigment Cell & Melanoma Research
|
November 20, 2015
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma
Virginia Andreotti, Alessandra Bisio, Brigitte Bressac-de Paillerets, et al.
Cancers
|
August 14, 2019
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
Sara Gomes, Bartolomeo Bosco, Joana B Loureiro, et al.
Cell Reports
|
April 14, 2021
A selective p53 activator and anticancer agent to improve colorectal cancer therapy
Helena Ramos, Maria I L Soares, Joana Silva, et al.
Page
of 11